$BDX
BECTON DICKINSON & CO Stock $bdx

$bdx Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-K Financial Statement

#000001079521000091 Filed on November 24, 2021

Income Statement

Concept	2021 Q3	2021	2020 Q3
Revenue	$5.135B	$20.25B	$4.784B
YoY Change	7.34%	18.29%	4.36%
Cost Of Revenue	$2.848B	$10.82B	$2.519B
YoY Change	13.06%	13.43%	8.67%
Gross Profit	$2.287B	$9.427B	$2.206B
YoY Change	3.67%	24.42%	-2.65%
Gross Profit Margin	44.54%	46.56%	46.11%
Selling, General & Admin	$1.332B	$4.867B	$1.199B
YoY Change	11.09%	12.53%	9.6%
% of Gross Profit	58.24%	51.63%	54.35%
Research & Development	$387.0M	$1.339B	$299.0M
YoY Change	29.43%	22.17%	10.74%
% of Gross Profit	16.92%	14.2%	13.55%
Depreciation & Amortization	$625.0M	$2.273B	$553.0M
YoY Change	13.02%	5.52%	0.0%
% of Gross Profit	27.33%	24.11%	25.07%
Operating Expenses	$1.803B	$6.206B	$1.877B
YoY Change	-3.94%	14.48%	-4.04%
Operating Profit	$484.0M	$2.799B	$329.0M
YoY Change	47.11%	88.61%	6.13%
Interest Expense	-$109.0M	$469.0M	-$121.0M
YoY Change	-9.92%	-11.17%	-11.68%
% of Operating Profit	-22.52%	16.76%	-36.78%
Other Income/Expense, Net	$28.00M	-$97.00M	$9.000M
YoY Change	211.11%	-521.74%	-62.5%
Pretax Income	$266.0M	$2.242B	$143.0M
YoY Change	86.01%	127.61%	-7250.0%
Income Tax	$1.000M	$150.0M	$15.00M
% Of Pretax Income	0.38%	6.69%	10.49%
Net Earnings	$265.0M	$2.092B	$128.0M
YoY Change	107.03%	139.36%	-21.47%
Net Earnings / Revenue	5.16%	10.33%	2.68%
Basic Earnings Per Share		$6.92	$0.36
Diluted Earnings Per Share	$916.7K	$6.85	$0.36
COMMON SHARES
Basic Shares Outstanding		289.3M shares
Diluted Shares Outstanding		292.1M shares

Balance Sheet

Concept	2021 Q3	2021	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.295B	$2.295B	$2.845B
YoY Change	-19.33%	-19.33%	402.65%
Cash & Equivalents	$2.283B	$2.283B	$2.825B
Short-Term Investments	$12.00M	$12.00M	$20.00M
Other Short-Term Assets	$1.048B	$1.180B	$891.0M
YoY Change	17.62%	20.04%	-20.38%
Inventory	$2.743B	$2.866B	$2.743B
Prepaid Expenses
Receivables	$2.350B	$2.497B	$2.398B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.838B	$8.838B	$8.969B
YoY Change	-1.46%	-1.46%	34.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.003B	$6.393B	$5.923B
YoY Change	1.35%	7.94%	4.67%
Goodwill	$23.89B		$23.62B
YoY Change	1.13%		1.04%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.945B	$1.951B	$1.687B
YoY Change	15.29%	15.65%	55.06%
Total Long-Term Assets	$45.03B	$45.03B	$45.04B
YoY Change	-0.03%	-0.03%	-0.13%
TOTAL ASSETS
Total Short-Term Assets	$8.838B	$8.838B	$8.969B
Total Long-Term Assets	$45.03B	$45.03B	$45.04B
Total Assets	$53.87B	$53.87B	$54.01B
YoY Change	-0.27%	-0.27%	4.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.793B	$1.793B	$1.355B
YoY Change	32.32%	32.32%	24.08%
Accrued Expenses	$2.943B	$4.157B	$2.638B
YoY Change	11.56%	14.49%	24.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$500.0M	$0.00
YoY Change		9900.0%
Long-Term Debt Due	$500.0M	$0.00	$707.0M
YoY Change	-29.28%	-100.0%	-45.99%
Total Short-Term Liabilities	$6.626B	$6.626B	$5.836B
YoY Change	13.54%	13.54%	3.2%
LONG-TERM LIABILITIES
Long-Term Debt	$17.11B	$17.11B	$17.22B
YoY Change	-0.66%	-0.66%	-4.74%
Other Long-Term Liabilities	$5.209B	$1.228B	$5.753B
YoY Change	-9.46%	-14.37%	1.36%
Total Long-Term Liabilities	$22.32B	$18.34B	$22.98B
YoY Change	-2.86%	-1.72%	-3.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.626B	$6.626B	$5.836B
Total Long-Term Liabilities	$22.32B	$18.34B	$22.98B
Total Liabilities	$28.95B	$30.19B	$28.81B
YoY Change	0.46%	-0.19%	-2.04%
SHAREHOLDERS EQUITY
Retained Earnings	$13.83B		$12.79B
YoY Change	8.09%		-0.94%
Common Stock	$19.64B		$19.64B
YoY Change	0.01%		18.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.723B		$6.138B
YoY Change	25.82%		-0.84%
Treasury Stock Shares	80.16M shares		74.62M shares
Shareholders Equity	$23.68B	$23.68B	$23.77B
YoY Change
Total Liabilities & Shareholders Equity	$53.87B	$53.87B	$54.01B
YoY Change	-0.27%	-0.27%	4.34%

Cashflow Statement

Concept	2021 Q3	2021	2020 Q3
OPERATING ACTIVITIES
Net Income	$265.0M	$2.092B	$128.0M
YoY Change	107.03%	139.36%	-21.47%
Depreciation, Depletion And Amortization	$625.0M	$2.273B	$553.0M
YoY Change	13.02%	5.52%	0.0%
Cash From Operating Activities	$949.0M	$4.647B	$1.481B
YoY Change	-35.92%	31.31%	8.02%
INVESTING ACTIVITIES
Capital Expenditures	-$489.0M	$1.231B	-$213.0M
YoY Change	129.58%	51.98%	-40.5%
Acquisitions		$508.0M
YoY Change		209.76%
Other Investing Activities	-$205.0M	$142.0M	-$114.0M
YoY Change	79.82%	-44.75%	37.35%
Cash From Investing Activities	-$694.0M	-$1.880B	-$327.0M
YoY Change	112.23%	52.6%	-25.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.750B
YoY Change
Debt Paid & Issued, Net		$5.112B
YoY Change		9.61%
Cash From Financing Activities	-1.142B	-$3.306B	-1.208B
YoY Change	-5.46%	-15127.27%	30.88%
NET CHANGE
Cash From Operating Activities	949.0M	$4.647B	1.481B
Cash From Investing Activities	-694.0M	-$1.880B	-327.0M
Cash From Financing Activities	-1.142B	-$3.306B	-1.208B
Net Change In Cash	-887.0M	-$525.0M	-54.00M
YoY Change	1542.59%	-122.57%	-871.43%
FREE CASH FLOW
Cash From Operating Activities	$949.0M	$4.647B	$1.481B
Capital Expenditures	-$489.0M	$1.231B	-$213.0M
Free Cash Flow	$1.438B	$3.416B	$1.694B
YoY Change	-15.11%	25.17%	-2.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000010795
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-4802
CY2021	dei	Entity Registrant Name EntityRegistrantName	BECTON, DICKINSON AND COMPANY
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NJ
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-0760120
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Becton Drive,
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Franklin Lakes,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07417-1880
CY2021	dei	City Area Code CityAreaCode	201
CY2021	dei	Local Phone Number LocalPhoneNumber	847-6800
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Public Float EntityPublicFloat	70616222365	USD
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	284023582	shares
CY2021	us-gaap	Revenues Revenues	20248000000	USD
CY2020	us-gaap	Revenues Revenues	17117000000	USD
CY2019	us-gaap	Revenues Revenues	17290000000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10821000000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9540000000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9002000000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4867000000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4325000000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4332000000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1339000000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1096000000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1062000000	USD
CY2021	bdx	Acquisition Related Costs And Restructuring Charges AcquisitionRelatedCostsAndRestructuringCharges	185000000	USD
CY2020	bdx	Acquisition Related Costs And Restructuring Charges AcquisitionRelatedCostsAndRestructuringCharges	309000000	USD
CY2019	bdx	Acquisition Related Costs And Restructuring Charges AcquisitionRelatedCostsAndRestructuringCharges	480000000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-238000000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-363000000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-654000000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	17449000000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	15633000000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	15530000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	2799000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	1484000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	1760000000	USD
CY2021	us-gaap	Interest Expense InterestExpense	469000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	528000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	639000000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-97000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2242000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	985000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1176000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	150000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-57000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2092000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	874000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1233000000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	90000000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	107000000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	152000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2002000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	767000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1082000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.92
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.75
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.85
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.71
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.94
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2092000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	874000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1233000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	124000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-161000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-93000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-255000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	35000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	275000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	81000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-67000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-6000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	460000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-265000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-374000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2552000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	609000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	859000000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2283000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2825000000	USD
CY2021Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	109000000	USD
CY2020Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	92000000	USD
CY2021Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	12000000	USD
CY2020Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	20000000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2497000000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2398000000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	2866000000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	2743000000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1072000000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	891000000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	8838000000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	8969000000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6393000000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5923000000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	23901000000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	23620000000	USD
CY2021Q3	bdx	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	9417000000	USD
CY2020Q3	bdx	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	10146000000	USD
CY2021Q3	bdx	Finite Lived Customer Relationships Net FiniteLivedCustomerRelationshipsNet	2818000000	USD
CY2020Q3	bdx	Finite Lived Customer Relationships Net FiniteLivedCustomerRelationshipsNet	3107000000	USD
CY2021Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	548000000	USD
CY2020Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	560000000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1952000000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1355000000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1687000000	USD
CY2021Q3	us-gaap	Assets Assets	53866000000	USD
CY2020Q3	us-gaap	Assets Assets	54012000000	USD
CY2021Q3	us-gaap	Debt Current DebtCurrent	500000000	USD
CY2020Q3	us-gaap	Debt Current DebtCurrent	707000000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1793000000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2943000000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2638000000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1214000000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	993000000	USD
CY2021Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	176000000	USD
CY2020Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	144000000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6626000000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5836000000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17110000000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17224000000	USD
CY2021Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1228000000	USD
CY2020Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1435000000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5225000000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5753000000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	2000000	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	2000000	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	640000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	640000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364639901	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364639901	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	365000000	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	365000000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	19272000000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	19270000000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13826000000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12791000000	USD
CY2021Q3	bdx	Common Stock Shares Held In Employee Trust1 CommonStockSharesHeldInEmployeeTrust1	23000000	USD
CY2020Q3	bdx	Common Stock Shares Held In Employee Trust1 CommonStockSharesHeldInEmployeeTrust1	23000000	USD
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	80163949	shares
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	74622657	shares
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	7723000000	USD
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	6138000000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2088000000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2548000000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	23677000000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	23765000000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53866000000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54012000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2092000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	874000000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1233000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2273000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2154000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2253000000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	237000000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	244000000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	261000000	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-304000000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-302000000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-381000000	USD
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	95000000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	48000000	USD
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	51000000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	104000000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	125000000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	149000000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	186000000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-81000000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-299000000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	687000000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	205000000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-470000000	USD
CY2021	bdx	Increase Decreasein Pension Benefit Obligation IncreaseDecreaseinPensionBenefitObligation	71000000	USD
CY2020	bdx	Increase Decreasein Pension Benefit Obligation IncreaseDecreaseinPensionBenefitObligation	95000000	USD
CY2019	bdx	Increase Decreasein Pension Benefit Obligation IncreaseDecreaseinPensionBenefitObligation	-123000000	USD
CY2021	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-15000000	USD
CY2020	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-52000000	USD
CY2019	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-55000000	USD
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	336000000	USD
CY2021	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	361000000	USD
CY2020	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	378000000	USD
CY2019	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	914000000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	400000000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	68000000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	177000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4647000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3539000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3330000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1231000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	810000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	957000000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	508000000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	164000000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	477000000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	142000000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	257000000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	261000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1880000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1232000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-741000000	USD
CY2021	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
CY2020	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-485000000	USD
CY2019	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	485000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4869000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3389000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2224000000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5112000000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4664000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4744000000	USD
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2917000000	USD
CY2019	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1750000000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1048000000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1026000000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	984000000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-265000000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-109000000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-205000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3306000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3223000000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15000000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-12000000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-525000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2326000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-646000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2917000000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	590000000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1236000000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2392000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2917000000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	590000000	USD
CY2021	us-gaap	Depreciation Depreciation	731000000	USD
CY2020	us-gaap	Depreciation Depreciation	646000000	USD
CY2019	us-gaap	Depreciation Depreciation	633000000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.</span></div>
CY2019	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.08
CY2020	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.16
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.32
CY2021	bdx	Number Of Accelerated Share Repurchase Agreements NumberOfAcceleratedShareRepurchaseAgreements	2	lawsuit
CY2021Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	10000000	shares
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1909000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-427000000	USD
CY2019	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-52000000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2283000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-338000000	USD
CY2020	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-74000000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2548000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	383000000	USD
CY2021	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-77000000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2088000000	USD
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	42000000	USD
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	-30000000	USD
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	-91000000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	289288000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	278971000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	269943000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2801000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3431000	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4832000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	292089000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	282402000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	274775000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	1670000000	USD
CY2021Q3	bdx	Number Of Days To Replead NumberOfDaysToReplead	45	lawsuit
CY2021Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2500000000	USD
CY2020Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2500000000	USD
CY2021Q3	bdx	Qualified Settlement Funds QualifiedSettlementFunds	106000000	USD
CY2020Q3	bdx	Qualified Settlement Funds QualifiedSettlementFunds	92000000	USD
CY2021Q3	us-gaap	Loss Contingency Receivable LossContingencyReceivable	93000000	USD
CY2020Q3	us-gaap	Loss Contingency Receivable LossContingencyReceivable	139000000	USD
CY2021Q3	bdx	Contract With Customer Rebate Liability ContractWithCustomerRebateLiability	576000000	USD
CY2020Q3	bdx	Contract With Customer Rebate Liability ContractWithCustomerRebateLiability	526000000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3Y
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021	bdx	Number Of Customer Accounted For Ten Percent Or More Of Revenue NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue	0	customer
CY2020	bdx	Number Of Customer Accounted For Ten Percent Or More Of Revenue NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue	0	customer
CY2019	bdx	Number Of Customer Accounted For Ten Percent Or More Of Revenue NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue	0	customer
CY2021	us-gaap	Revenues Revenues	20248000000	USD
CY2020	us-gaap	Revenues Revenues	17117000000	USD
CY2019	us-gaap	Revenues Revenues	17290000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2242000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	985000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1176000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1231000000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	810000000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	957000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2273000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2154000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2253000000	USD
CY2021	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	361000000	USD
CY2021	us-gaap	Revenues Revenues	20248000000	USD
CY2020	us-gaap	Revenues Revenues	17117000000	USD
CY2019	us-gaap	Revenues Revenues	17290000000	USD
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	45029000000	USD
CY2020Q3	us-gaap	Noncurrent Assets NoncurrentAssets	45043000000	USD
CY2019Q3	us-gaap	Noncurrent Assets NoncurrentAssets	45101000000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	238000000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	245000000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	265000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	55000000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	57000000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	62000000	USD
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Award Vesting Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod	P4Y
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward	P10Y
CY2021	bdx	Stock Issued Under Stock Appreciation Rights Exercised StockIssuedUnderStockAppreciationRightsExercised	400000	shares
CY2020Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber	6337000	shares
CY2020Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice	167.17
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod	1097000	shares
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice	227.83
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod	842000	shares
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice	128.13
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod	297000	shares
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice	237.47
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber	6295000	shares
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice	179.64
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P5Y6M3D
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue	424000000	USD
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber	6113000	shares
CY2021	bdx	Percentage Of Target Payout On Which Performance Based Restricted Stock Units Are Based PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased	2
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	177.94
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm	P5Y5M1D
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	421000000	USD
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber	4471000	shares
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice	156.28
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm	P4Y3M21D
CY2021Q3	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue	403000000	USD
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue	102000000	USD
CY2020	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue	212000000	USD
CY2019	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue	260000000	USD
CY2021	bdx	Fair Value Of Stock Appreciation Rights FairValueOfStockAppreciationRights	39000000	USD
CY2020	bdx	Fair Value Of Stock Appreciation Rights FairValueOfStockAppreciationRights	46000000	USD
CY2019	bdx	Fair Value Of Stock Appreciation Rights FairValueOfStockAppreciationRights	66000000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	111000000	USD
CY2021	bdx	Percentage Of Target Payout On Which Performance Based Time Vested Restricted Stock Units Are Based PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased	1
CY2021	bdx	Percentage Of Target Payout On Which Performance Based Time Vested Restricted Stock Units Are Based PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased	1
CY2021	bdx	Expected Forfeited Performance Based Restricted Stock Units ExpectedForfeitedPerformanceBasedRestrictedStockUnits	63000	shares
CY2021	bdx	Units In Excess Of Expected Performance Payout UnitsInExcessOfExpectedPerformancePayout	555000	shares
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	247000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y11M8D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	8600000	shares
CY2021Q3	bdx	Shares Issuable Under Deferred Compensation Plan SharesIssuableUnderDeferredCompensationPlan	259000	shares
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	153000000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	3475000000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	3920000000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation	3309000000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation	3703000000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	2712000000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	2936000000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	2780000000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	2996000000	USD
CY2021	bdx	Percent Of Assets Domestic Plans PercentOfAssetsDomesticPlans	0.68
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	126000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20122000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7385000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12737000000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19748000000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5981000000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13767000000	USD
CY2021Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	46000000	USD
CY2020Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	46000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1403000000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1384000000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1497000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1399000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1386000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1384000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1383000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1357000000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	23376000000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	117000000	USD
CY2020	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	5000000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-122000000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	23620000000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	264000000	USD
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	6000000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-12000000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	23901000000	USD
CY2021Q3	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	1000000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2283000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2825000000	USD
CY2021Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	109000000	USD
CY2020Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	92000000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2392000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2917000000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	200000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1549000000	USD
CY2021Q3	bdx	Fair Value Of Debt Classified From Long Term To Short Term FairValueOfDebtClassifiedFromLongTermToShortTerm	503000000	USD
CY2020Q3	bdx	Fair Value Of Debt Classified From Long Term To Short Term FairValueOfDebtClassifiedFromLongTermToShortTerm	702000000	USD
CY2021Q3	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	18537000000	USD
CY2020Q3	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	18970000000	USD
CY2021Q3	bdx	Remaining Cash Equivalents RemainingCashEquivalents	2083000000.000	USD
CY2020Q3	bdx	Remaining Cash Equivalents RemainingCashEquivalents	1276000000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company’s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company’s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its accounts receivables for potential collection risks particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries as payment may be dependent upon the financial stability and creditworthiness of those countries’ national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company </span></div>believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.
CY2021	bdx	Transfers Of Financial Assets During The Period TransfersOfFinancialAssetsDuringThePeriod	1302000000	USD
CY2020	bdx	Transfers Of Financial Assets During The Period TransfersOfFinancialAssetsDuringThePeriod	2163000000	USD
CY2021Q3	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	130000000	USD
CY2020Q3	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	256000000	USD
CY2021Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	0	USD
CY2020Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	5000000	USD
CY2021Q3	us-gaap	Debt Current DebtCurrent	500000000	USD
CY2020Q3	us-gaap	Debt Current DebtCurrent	707000000	USD
CY2021Q3	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0115
CY2020Q3	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0020
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17110000000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17224000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	433000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2749000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1559000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2164000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1053000000.000	USD
CY2021Q3	bdx	Letters Of Credit Issuable Under Credit Facility LettersOfCreditIssuableUnderCreditFacility	100000000	USD
CY2021Q3	bdx	Swingline Loans Issuable Under Credit Facility SwinglineLoansIssuableUnderCreditFacility	100000000	USD
CY2021Q3	bdx	Line Of Credit Facility Maximum Additional Principal Amount Commitments LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments	500000000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	3250000000	USD
CY2021Q3	us-gaap	Longterm Commercial Paper Current And Noncurrent LongtermCommercialPaperCurrentAndNoncurrent	0	USD
CY2020Q3	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	951000000	USD
CY2020Q3	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-1000000	USD
CY2020	us-gaap	Debt Instrument Term DebtInstrumentTerm	P364D
CY2021	us-gaap	Interest Expense InterestExpense	469000000	USD
CY2020	us-gaap	Interest Expense InterestExpense	528000000	USD
CY2019	us-gaap	Interest Expense InterestExpense	639000000	USD
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	44000000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	43000000	USD
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	44000000	USD
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	512000000	USD
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	571000000	USD
CY2019	us-gaap	Interest Costs Incurred InterestCostsIncurred	683000000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	474000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	515000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	658000000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-101000000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	102000000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-50000000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	235000000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	46000000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	47000000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	41000000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	290000000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	400000000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	300000000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	438000000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	397000000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	576000000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-286000000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-184000000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-577000000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2000000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-56000000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-288000000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-286000000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-633000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	150000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-57000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	133000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-489000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	799000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2109000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1474000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	377000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2242000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	985000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1176000000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2019	bdx	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate New EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateNew	0.21
CY2019	us-gaap	Tax Cuts And Jobs Act Of2017 Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit	-50000000	USD
CY2021	bdx	Other Tax Expense Benefit Relatedto Historic Unremitted Foreign Earnings OtherTaxExpenseBenefitRelatedtoHistoricUnremittedForeignEarnings	-138000000	USD
	bdx	Other Tax Expense Benefit Relatedto Historic Unremitted Foreign Earnings OtherTaxExpenseBenefitRelatedtoHistoricUnremittedForeignEarnings	-67000000	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	620000000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	577000000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	601000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	3000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	23000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	35000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	11000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	76000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	4000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	49000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	39000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	183000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	4000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	100000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	16000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	5000000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	364000000	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	620000000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	577000000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	447000000	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	719000000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	624000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	5000000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	1000000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	26000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	527000000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	554000000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	410000000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	361000000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	2160000000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	2408000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	2107000000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	1900000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	191000000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	241000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	555000000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	123000000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	501000000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	137000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3379000000	USD
CY2021Q3	bdx	Deferred Tax Liabilities Gross DeferredTaxLiabilitiesGross	2693000000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3196000000	USD
CY2020Q3	bdx	Deferred Tax Liabilities Gross DeferredTaxLiabilitiesGross	2906000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2036000000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1820000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1343000000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2693000000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1376000000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2906000000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M24D
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	-0.191
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	0.055
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	-0.043
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.019
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.019
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.081
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.148
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.066
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.016
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.050
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.033
CY2021	bdx	Effective Income Tax Rate Reconciliation Benefit From Share Based Compensation EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation	0.001
CY2020	bdx	Effective Income Tax Rate Reconciliation Benefit From Share Based Compensation EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation	-0.045
CY2019	bdx	Effective Income Tax Rate Reconciliation Benefit From Share Based Compensation EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation	-0.039
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	-0.045
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	-0.020
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.017
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.010
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.019
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.067
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.113
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.048
CY2021	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	248000000	USD
CY2020	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	136000000	USD
CY2019	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	-43000000	USD
CY2021	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.85
CY2020	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.48
CY2019	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	-0.16
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	670000000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	518000000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	536000000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.022
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	132000000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	131000000	USD
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	169000000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	446000000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	418000000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	126000000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	106000000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	344000000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	336000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	134000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	96000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	63000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	45000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	37000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	140000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	515000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	45000000	USD
CY2021	bdx	Gross Proceeds From Sale Leaseback Transaction GrossProceedsFromSaleLeasebackTransaction	225000000	USD
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	57000000	USD
CY2020	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	13000000	USD
CY2019	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	18000000	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-13000000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-17000000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-23000000	USD
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-178000000	USD
CY2020	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-8000000	USD
CY2019	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-59000000	USD
CY2021	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	0	USD
CY2020	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	17000000	USD
CY2019	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	64000000	USD
CY2021	us-gaap	Insurance Recoveries InsuranceRecoveries	0	USD
CY2020	us-gaap	Insurance Recoveries InsuranceRecoveries	0	USD
CY2019	us-gaap	Insurance Recoveries InsuranceRecoveries	35000000	USD
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3000000	USD
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3000000	USD
CY2019	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-4000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-97000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000000	USD
CY2018Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	86000000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	125000000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	123000000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6393000000	USD
CY2019Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	88000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	78000000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	73000000	USD
CY2020Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	94000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	118000000	USD
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	114000000	USD
CY2021Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	97000000	USD
CY2021Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	641000000	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	602000000	USD
CY2021Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	402000000	USD
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	335000000	USD
CY2021Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1823000000	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1806000000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	2866000000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	2743000000	USD
CY2021Q3	us-gaap	Land Land	137000000	USD
CY2020Q3	us-gaap	Land Land	166000000	USD
CY2021Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3264000000	USD
CY2020Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3082000000	USD
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	9301000000	USD
CY2020Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	8454000000	USD
CY2021Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	241000000	USD
CY2020Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	216000000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12942000000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11919000000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6549000000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5996000000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5923000000	USD

Files In Submission

Name	View Source	Status
0000010795-21-000091-index-headers.html	Edgar Link	pending
0000010795-21-000091-index.html	Edgar Link	pending
0000010795-21-000091.txt	Edgar Link	pending
0000010795-21-000091-xbrl.zip	Edgar Link	pending
a09-30x2021ex10n.htm	Edgar Link	pending
a09-30x2021ex21nextgenfina.htm	Edgar Link	pending
a09-30x2021ex22.htm	Edgar Link	pending
a09-30x2021ex23_nextgen.htm	Edgar Link	pending
a09-30x2021ex31_nextgen.htm	Edgar Link	pending
a09-30x2021ex32_nextgen.htm	Edgar Link	pending
a09-30x2021ex4ll.htm	Edgar Link	pending
bdx-20210930.htm	Edgar Link	pending
bdx-20210930.xsd	Edgar Link	pending
bdx-20210930_cal.xml	Edgar Link	unprocessable
bdx-20210930_def.xml	Edgar Link	unprocessable
bdx-20210930_htm.xml	Edgar Link	completed
bdx-20210930_lab.xml	Edgar Link	unprocessable
bdx-20210930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDX
BECTON DICKINSON & CO Stock $bdx

2021 Q3 Form 10-K Financial Statement

#000001079521000091 Filed on November 24, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDX BECTON DICKINSON & CO Stock $bdx

2021 Q3 Form 10-K Financial Statement

#000001079521000091 Filed on November 24, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDX
BECTON DICKINSON & CO Stock $bdx